Avanos Medical Expects Adjusted Diluted EPS Of $1.05-$1.15 For FY23, Vs. Consensus Of $1.52
Portfolio Pulse from Benzinga Newsdesk
Avanos Medical, Inc. (NYSE:AVNS) has projected an adjusted diluted EPS of $1.05-$1.15 for FY23, which is lower than the consensus of $1.52. The company also anticipates low single-digit organic growth and adjusted gross margins greater than 59% for the second half of 2023.
August 09, 2023 | 11:22 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Avanos Medical's lower than expected EPS forecast for FY23 may negatively impact its stock price in the short term.
Avanos Medical's EPS forecast for FY23 is lower than the market consensus, which could lead to a negative sentiment among investors and potentially a decrease in the stock price. However, the company's expectation of low single-digit organic growth and higher gross margins could partially offset this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100